Literature DB >> 2938072

Quinolones and colonization resistance in human volunteers.

J J Van Saene, H K Van Saene, J N Geitz, N J Tarko-Smit, C F Lerk.   

Abstract

The suppression of alimentary canal flora by the three quinolones nalidixic acid, ciprofloxacin and pefloxacin was investigated in fifteen volunteers. They received the three quinolone compounds in tablet form both uncoated and colon-coated. Escherichia coli suppression was poor under nalidixic acid, but complete under ciprofloxacin and pefloxacin for both administration forms. The indigenous anaerobic flora contributing to the control of aerobic Streptococcus faecalis and Candida albicans in the intestines ('colonization resistance') was not affected by nalidixic acid and pefloxacin, and only slightly by ciprofloxacin. Out of the three quinolone compounds, only colon-coated pefloxacin was associated with a considerable absorption rate at colonic level. Using these criteria of successful Escherichia coli clearing from the intestinal canal--left the indigenous flora more or less intact (in a 'selective' way)--and a good absorption rate, pefloxacin is found to be superior to ciprofloxacin and nalidixic acid. These results suggest that a colon-coated tablet with a low dose of pefloxacin is a promising administration form in the therapy of recurrent urinary tract infections and diarrhoeal diseases and in the prevention of gut colonization in immunocompromised hosts.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2938072     DOI: 10.1007/bf01975484

Source DB:  PubMed          Journal:  Pharm Weekbl Sci        ISSN: 0167-6555


  13 in total

1.  Prophylaxis of recurring urinary tract infection in females: a comparison of nitrofurantoin with trimethoprim-sulfamethoxazole.

Authors:  A R Ronald; C K Harding; R Mathias; C K Wong; P Muir
Journal:  Can Med Assoc J       Date:  1975-06-14       Impact factor: 8.262

2.  Recurrent urinary infections in adult women. The role of introital enterobacteria.

Authors:  T A Stamey; M Timothy; M Millar; G Mihara
Journal:  Calif Med       Date:  1971-07

3.  Changes in the pharmacokinetics of ciprofloxacin and fecal flora during administration of a 7-day course to human volunteers.

Authors:  W Brumfitt; I Franklin; D Grady; J M Hamilton-Miller; A Iliffe
Journal:  Antimicrob Agents Chemother       Date:  1984-11       Impact factor: 5.191

4.  A novel approach to infection control in the intensive care unit.

Authors:  H K Van Saene; C P Stoutenbeek; D R Miranda; D F Zandstra
Journal:  Acta Anaesthesiol Belg       Date:  1983-09

5.  Infection prevention in granulocytopenic patients by selective decontamination of the digestive tract.

Authors:  D T Sleijfer; N H Mulder; H G de Vries-Hospers; V Fidler; H O Nieweg; D van der Waaij; H K van Saene
Journal:  Eur J Cancer       Date:  1980-06       Impact factor: 9.162

6.  Origin of infection in acute nonlymphocytic leukemia. Significance of hospital acquisition of potential pathogens.

Authors:  S C Schimpff; V M Young; W H Greene; G D Vermeulen; M R Moody; P H Wiernik
Journal:  Ann Intern Med       Date:  1972-11       Impact factor: 25.391

7.  Colonization resistance of the digestive tract in conventional and antibiotic-treated mice.

Authors:  D van der Waaij; J M Berghuis-de Vries
Journal:  J Hyg (Lond)       Date:  1971-09

8.  A comparison of the efficacy of nalidixic acid and cephalexin in bacteriuric women and their effect on fecal and periurethral carriage of enterobacteriaceae.

Authors:  J K Preiksaitis; L Thompson; G K Harding; T J Marrie; S Hoban; A R Ronald
Journal:  J Infect Dis       Date:  1981-04       Impact factor: 5.226

9.  Selective antimicrobial modulation as prophylaxis against infection during granulocytopenia: trimethoprim-sulfamethoxazole vs. nalidixic acid.

Authors:  J C Wade; C A de Jongh; K A Newman; J Crowley; P H Wiernik; S C Schimpff
Journal:  J Infect Dis       Date:  1983-04       Impact factor: 5.226

10.  Ciprofloxacin for selective decontamination of the alimentary tract in patients with acute leukemia during remission induction treatment: the effect on fecal flora.

Authors:  M Rozenberg-Arska; A W Dekker; J Verhoef
Journal:  J Infect Dis       Date:  1985-07       Impact factor: 5.226

View more
  11 in total

1.  Excretion of ciprofloxacin into the large bowel of the rabbit.

Authors:  J Ramon; S Dautrey; R Farinoti; C Carbon; E Rubinstein
Journal:  Antimicrob Agents Chemother       Date:  1996-01       Impact factor: 5.191

Review 2.  Effect of quinolones on the human intestinal microflora.

Authors:  C E Nord
Journal:  Drugs       Date:  1995       Impact factor: 9.546

Review 3.  Effect of quinolones on intestinal ecology.

Authors:  C Edlund; C E Nord
Journal:  Drugs       Date:  1999       Impact factor: 9.546

4.  Decontaminating efficacy of ciprofloxacin in an animal model.

Authors:  M L van Ogtrop; H Mattie; H F Guiot; R van Furth
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-10       Impact factor: 3.267

Review 5.  Pefloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  J P Gonzalez; J M Henwood
Journal:  Drugs       Date:  1989-05       Impact factor: 9.546

Review 6.  A review on the impact of 4-quinolones on the normal oropharyngeal and intestinal human microflora.

Authors:  C Edlund; C E Nord
Journal:  Infection       Date:  1988       Impact factor: 3.553

Review 7.  Ofloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  J P Monk; D M Campoli-Richards
Journal:  Drugs       Date:  1987-04       Impact factor: 9.546

Review 8.  Ciprofloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  D M Campoli-Richards; J P Monk; A Price; P Benfield; P A Todd; A Ward
Journal:  Drugs       Date:  1988-04       Impact factor: 9.546

9.  Comparative effects of enoxacin and norfloxacin on human colonic microflora.

Authors:  C Edlund; A Lidbeck; L Kager; C E Nord
Journal:  Antimicrob Agents Chemother       Date:  1987-11       Impact factor: 5.191

Review 10.  Human gut microbiota: repertoire and variations.

Authors:  Jean-Christophe Lagier; Matthieu Million; Perrine Hugon; Fabrice Armougom; Didier Raoult
Journal:  Front Cell Infect Microbiol       Date:  2012-11-02       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.